Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lignocaine Nebulization for Intubation Stress in Severe Pre-eclampsia
NCT04441073Phase 4Unknown
- Sponsor
- Assiut University
- Start
- Feb 2021
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in preeclampsia comparing Lignocaine with Placebo (2 arms). Primary endpoints: Systolic, diastolic, mean arterial blood pressure, Heart rate and 2 more. Status: unknown.
02
Drugs
lidocaine
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT04441073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04441073.